# PREMIUM Migraine Trial

> **NCT00355056** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 230 (actual)

## Conditions studied

- Migraine Headaches
- Patent Foramen Ovale

## Interventions

- **OTHER:** Sham Procedure
- **DEVICE:** AMPLATZER PFO Occluder

## Key facts

- **NCT ID:** NCT00355056
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-12
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355056, "PREMIUM Migraine Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00355056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*